Long-term management of patients who have experienced myxedema coma requires strict adherence to thyroid hormone replacement therapy, regular monitoring of thyroid function, and follow-up with endocrinology to ensure adequate control of hypothyroidism [18]. This evidence concerns the gene TG and hypothyroidism.